Methods for Treating a Neoplastic Disease in a Subject Using Inorganic Selenium-Containing Compounds
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsSUSAN J. KNOX, BRYAN HUSBECK
Life of this patent
Estimating the term…
Abstract
The invention features methods and selenium-containing compositions for treating a neoplastic disease in a subject. In particular, the invention features methods for enhancing sensitivity of a tumor to cancer therapy by treating the tumor with an inorganic selenium-containing (iSe) compound and with a cancer therapy, particularly a cancer therapy that also affects the cellular redox status of a tumor cell (e.g., radiation).
Claims20
A method of treating a neoplastic disease in a subject, the method comprising:
- administering to a subject having a tumor a pharmaceutically acceptable salt of an inorganic selenium-containing compound (iSe compound) in an amount effective to alter a reduction-oxidation state of a tumor cell toward oxidation;
- and
- administering a cancer therapy other than an iSe compound to the subject;
- wherein the neoplastic disease in the subject is treated.
A method of enhancing sensitivity of a tumor in a subject to a cancer therapy, the method comprising:
- administering to a subject having a tumor a pharmaceutically acceptable salt of an inorganic selenium-containing (iSe) compound in an amount effective to sensitize the tumor to a cancer therapy;
- and
- administering the cancer therapy to the subject;
- wherein administration of the iSe compound is effective to enhance sensitivity of the tumor to the cancer therapy.
A method of treating prostate cancer, the method comprising:
- administering to a subject having prostate cancer a pharmaceutically acceptable salt of an inorganic selenite;
- and
- administering a cancer therapy other than inorganic selenite to the subject;
- wherein administering the inorganic selenite and the cancer therapy provides for a synergistic effect in prostate cancer cell growth inhibition to treat the prostate cancer.
Dependencies are inferred from the claim text.